A 115-Bp MethyLight Assay for Detection of P16 (CDKN2A) Methylation as a Diagnostic Biomarker in Human Tissues

BMC Medical Genetics - United Kingdom
doi 10.1186/1471-2350-12-67
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Diagnostic Value of P16 Methylation for Malignant Pleural Effusions: A Meta-Analysis

West Indian Medical Journal
Medicine
2014English

Rapid Diagnostic Assay for Detection of Cellulose in Urine as Biomarker for Biofilm-Related Urinary Tract Infections

npj Biofilms and Microbiomes
Applied MicrobiologyBiotechnologyMicrobiology
2018English

Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Infrequent Methylation of CDKN2A(MTS1/p16) and Rare Mutation of Both CDKN2A and CDKN2B(MTS2/p15) in Primary Astrocytic Tumours

British Journal of Cancer
Cancer ResearchOncology
1997English

DNA Methylation as a Universal Biomarker

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2010English

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Gene Methylation as a Powerful Biomarker for Detection and Screening of Non-Small Cell Lung Cancer in Blood

Oncotarget
Oncology
2017English

Universal Assay of Vitellogenin as a Biomarker for Environmental Estrogens

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy